These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32319557)

  • 1. Prostate field cancerization and exosomes: Association between CD9, early growth response 1 and fatty acid synthase.
    Amirrad F; Pytak PA; Sadeghiani-Pelar N; Nguyen JPT; Cauble EL; Jones AC; Bisoffi M
    Int J Oncol; 2020 Apr; 56(4):957-968. PubMed ID: 32319557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association and regulation of protein factors of field effect in prostate tissues.
    Gabriel KN; Jones AC; Nguyen JP; Antillon KS; Janos SN; Overton HN; Jenkins SM; Frisch EH; Trujillo KA; Bisoffi M
    Int J Oncol; 2016 Oct; 49(4):1541-1552. PubMed ID: 27634112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early growth response 1 and fatty acid synthase expression is altered in tumor adjacent prostate tissue and indicates field cancerization.
    Jones AC; Trujillo KA; Phillips GK; Fleet TM; Murton JK; Severns V; Shah SK; Davis MS; Smith AY; Griffith JK; Fischer EG; Bisoffi M
    Prostate; 2012 Aug; 72(11):1159-70. PubMed ID: 22127986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate field cancerization: deregulated expression of macrophage inhibitory cytokine 1 (MIC-1) and platelet derived growth factor A (PDGF-A) in tumor adjacent tissue.
    Jones AC; Antillon KS; Jenkins SM; Janos SN; Overton HN; Shoshan DS; Fischer EG; Trujillo KA; Bisoffi M
    PLoS One; 2015; 10(3):e0119314. PubMed ID: 25767870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer sheds the αvβ3 integrin in vivo through exosomes.
    Krishn SR; Singh A; Bowler N; Duffy AN; Friedman A; Fedele C; Kurtoglu S; Tripathi SK; Wang K; Hawkins A; Sayeed A; Goswami CP; Thakur ML; Iozzo RV; Peiper SC; Kelly WK; Languino LR
    Matrix Biol; 2019 Apr; 77():41-57. PubMed ID: 30098419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomolecular characterization of exosomes released from cancer stem cells: Possible implications for biomarker and treatment of cancer.
    Kumar D; Gupta D; Shankar S; Srivastava RK
    Oncotarget; 2015 Feb; 6(5):3280-91. PubMed ID: 25682864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional prostate-specific membrane antigen is enriched in exosomes from prostate cancer cells.
    Liu T; Mendes DE; Berkman CE
    Int J Oncol; 2014 Mar; 44(3):918-22. PubMed ID: 24424840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoscale flow cytometry to distinguish subpopulations of prostate extracellular vesicles in patient plasma.
    Padda RS; Deng FK; Brett SI; Biggs CN; Durfee PN; Brinker CJ; Williams KC; Leong HS
    Prostate; 2019 May; 79(6):592-603. PubMed ID: 30680751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential gene expression in tumor adjacent histologically normal prostatic tissue indicates field cancerization.
    Haaland CM; Heaphy CM; Butler KS; Fischer EG; Griffith JK; Bisoffi M
    Int J Oncol; 2009 Sep; 35(3):537-46. PubMed ID: 19639174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FASN Protein Overexpression Indicates Poor Biochemical Recurrence-Free Survival in Prostate Cancer.
    Cao Z; Xu Y; Guo F; Chen X; Ji J; Xu H; He J; Yu Y; Sun Y; Lu X; Wang F
    Dis Markers; 2020; 2020():3904947. PubMed ID: 32655718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring a role for fatty acid synthase in prostate cancer cell migration.
    De Piano M; Manuelli V; Zadra G; Loda M; Muir G; Chandra A; Morris J; Van Hemelrijck M; Wells CM
    Small GTPases; 2021 Jul; 12(4):265-272. PubMed ID: 33043786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic profiling of exosomes leads to the identification of novel biomarkers for prostate cancer.
    Duijvesz D; Burnum-Johnson KE; Gritsenko MA; Hoogland AM; Vredenbregt-van den Berg MS; Willemsen R; Luider T; Paša-Tolić L; Jenster G
    PLoS One; 2013; 8(12):e82589. PubMed ID: 24391718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-Derived Exosomal Long Noncoding RNAs as Promising Diagnostic Biomarkers for Prostate Cancer.
    Wang YH; Ji J; Wang BC; Chen H; Yang ZH; Wang K; Luo CL; Zhang WW; Wang FB; Zhang XL
    Cell Physiol Biochem; 2018; 46(2):532-545. PubMed ID: 29614511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harnessing tumor-derived exosomes: A promising approach for the expansion of clinical diagnosis, prognosis, and therapeutic outcome of prostate cancer.
    Pirouzpanah MB; Babaie S; Pourzeinali S; Valizadeh H; Malekeh S; Şahin F; Farshbaf-Khalili A
    Biofactors; 2024; 50(4):674-692. PubMed ID: 38205673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer.
    Migita T; Ruiz S; Fornari A; Fiorentino M; Priolo C; Zadra G; Inazuka F; Grisanzio C; Palescandolo E; Shin E; Fiore C; Xie W; Kung AL; Febbo PG; Subramanian A; Mucci L; Ma J; Signoretti S; Stampfer M; Hahn WC; Finn S; Loda M
    J Natl Cancer Inst; 2009 Apr; 101(7):519-32. PubMed ID: 19318631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Exosomes in Prostate Cancer Metastasis.
    Akoto T; Saini S
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma-glutamyltransferase activity in exosomes as a potential marker for prostate cancer.
    Kawakami K; Fujita Y; Matsuda Y; Arai T; Horie K; Kameyama K; Kato T; Masunaga K; Kasuya Y; Tanaka M; Mizutani K; Deguchi T; Ito M
    BMC Cancer; 2017 May; 17(1):316. PubMed ID: 28476099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of the CD9 Tetraspanin on Lentivirus Infectivity and Exosome Secretion.
    Böker KO; Lemus-Diaz N; Rinaldi Ferreira R; Schiller L; Schneider S; Gruber J
    Mol Ther; 2018 Feb; 26(2):634-647. PubMed ID: 29221804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomes confer pro-survival signals to alter the phenotype of prostate cells in their surrounding environment.
    Hosseini-Beheshti E; Choi W; Weiswald LB; Kharmate G; Ghaffari M; Roshan-Moniri M; Hassona MD; Chan L; Chin MY; Tai IT; Rennie PS; Fazli L; Tomlinson Guns ES
    Oncotarget; 2016 Mar; 7(12):14639-58. PubMed ID: 26840259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomes as biomarker enriched microvesicles: characterization of exosomal proteins derived from a panel of prostate cell lines with distinct AR phenotypes.
    Hosseini-Beheshti E; Pham S; Adomat H; Li N; Tomlinson Guns ES
    Mol Cell Proteomics; 2012 Oct; 11(10):863-85. PubMed ID: 22723089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.